The biomarker potential of NCAPG2 is also reflected in the fact that its expression varies between the different pathological stages of the same tumor, with higher expression in the advanced stage of the tumor, which equally supported by the ROC diagnostic curve based on NCAPG2 expression levels and thus in a pan-cancer perspective. Here, NCAPG2 is linked to cancer.